Product
TBAJ-876
2 clinical trials
6 indications
Indication
Pulmonary DiseaseIndication
TuberculosisIndication
PulmonaryIndication
Multidrug-resistant tuberculosisIndication
Drug Sensitive TuberculosisIndication
Drug-resistant TuberculosisClinical trial
A Phase 1, Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, and the Induction Potential of TBAJ-876 on CYP3A4 and P-glycoprotein and the Inhibition Potential of TBAJ-876 on P-glycoprotein in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-08-28
Clinical trial
A Phase 2, Partially-blinded, Randomised Trial Assessing the Safety and Efficacy of TBAJ-876 or Bedaquiline, in Combination With Pretomanid and Linezolid in Adult Participants With Newly Diagnosed, Drug-sensitive, Smear-positive Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2025-02-01